A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

Clinical trial NCT00048152 · COMPLETED

Trial details

NCT number: NCT00048152
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Transplantation

Start date: 2000-12-01
Primary completion: 2006-03-01
Enrollment: 539

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.